FAP-targeted therapy demonstrates significant efficacy in controlling advanced sarcomas
Toronto, Ontario—Fibroblast activation protein (FAP)-targeted radioligand therapy is safe and effective for treating patients with progressive metastatic tumors, specifically advanced ...

